Hematological Oncology Journal Citation Rate 2026
0278-0232
eISSN 1099-1069
Wiley
GB
Q3 Quartile Verified Publisher
About Hematological Oncology
Hematological Oncology (HO) is a peer-reviewed academic journal covering CAR-T cell therapy research and CNS Lymphoma Diagnosis and Treatment, published by Wiley in GB, catalogued under ISSN 0278-0232 (e-ISSN 1099-1069). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 0.47 (Q3 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4220 USD). OpenAlex records 6,026 works and 41,757 citations, with an h-index of 73.
Hematological Oncology Citation Rate 2026 — In Context
Hematological Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 0.47, placing it in the Q3 quartile within the CAR-T cell therapy research research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Hematological Oncology operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Hematological Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Hematological Oncology against similar journals in the field, use our journal comparison tool.
Submission Tips for Hematological Oncology
- Budget $4220 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers CAR-T cell therapy research, CNS Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Hematological Oncology Compares
Compared against 24 journals in the same research areas.
| ISSN (Print) | 0278-0232 |
|---|---|
| ISSN (Online) | 1099-1069 |
| Publisher | Wiley |
| Country | United Kingdom |
| APC / Cost | $4220 USD |
In-depth profile & metrics
Hematological Oncology is published by Wiley and based in United Kingdom. It runs on a subscription or hybrid model with an article-processing charge of USD 4220.
In our subject taxonomy, Hematological Oncology is classified under CAR-T cell therapy research, CNS Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and Lymphoma Diagnosis and Treatment.
Hematological Oncology is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 0.468.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Hematological Oncology
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 0.468 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Hematological Oncology against similar publications in its field:
Related Journals in Your Field
-
Cancer Cell Elsevier IF 64.50
-
Journal for ImmunoTherapy of Cancer BMJ IF 7.57
-
Modern Pathology Elsevier BV IF 5.84
-
Leukemia Springer Nature IF 5.73
-
Molecular Therapy Elsevier BV IF 5.62
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S23714410
Get weekly updates for CAR-T cell therapy research journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.